Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387079244> ?p ?o ?g. }
- W4387079244 abstract "Currently approved pharmacotherapies for opioid use disorders (OUDs) and overdose reversal agents are insufficient to slow the spread of OUDs due to the proliferation of fentanyl. This is evident in the 31% rise in drug overdose deaths from 2019 to 2022, with rates increasing from 21.6 to 28.3 overdoses per 100,000 deaths. Vaccines are a potential alternative or adjunct therapy for the treatment of several substance use disorders (nicotine, cocaine) but have shown limited clinical success due to suboptimal antibody titers. In this study, we demonstrate that coconjugation of a Toll-like receptor 7/8 (TLR7/8) agonist (UM-3006) alongside a fentanyl-based hapten (F1) on the surface of the carrier protein cross-reactive material 197 (CRM) significantly increased generation of high-affinity fentanyl-specific antibodies. This demonstrated enhanced protection against fentanyl challenges relative to an unconjugated (admix) adjuvant control in mice. Inclusion of aluminum hydroxide (alum) adjuvant further increased titers and enhanced protection, as determined by analysis of fentanyl concentration in serum and brain tissue. Collectively, our findings present a promising approach to enhance the efficacy of antiopioid vaccines, underscoring the need for extensive exploration of TLR7/8 agonist conjugates as a compelling strategy to combat opioid use disorders." @default.
- W4387079244 created "2023-09-28" @default.
- W4387079244 creator A5027278009 @default.
- W4387079244 creator A5047686095 @default.
- W4387079244 creator A5049327145 @default.
- W4387079244 creator A5050762779 @default.
- W4387079244 creator A5056187776 @default.
- W4387079244 creator A5057401019 @default.
- W4387079244 creator A5058645388 @default.
- W4387079244 creator A5082093098 @default.
- W4387079244 creator A5084244796 @default.
- W4387079244 date "2023-09-27" @default.
- W4387079244 modified "2023-10-17" @default.
- W4387079244 title "Self-Adjuvanting TLR7/8 Agonist and Fentanyl Hapten Co-Conjugate Achieves Enhanced Protection against Fentanyl Challenge" @default.
- W4387079244 cites W1964269606 @default.
- W4387079244 cites W1986824448 @default.
- W4387079244 cites W1990954596 @default.
- W4387079244 cites W2002382248 @default.
- W4387079244 cites W2036970411 @default.
- W4387079244 cites W2041647537 @default.
- W4387079244 cites W2068438592 @default.
- W4387079244 cites W2069871552 @default.
- W4387079244 cites W2071956502 @default.
- W4387079244 cites W2072128323 @default.
- W4387079244 cites W2073023385 @default.
- W4387079244 cites W2083349939 @default.
- W4387079244 cites W2103386374 @default.
- W4387079244 cites W2112891300 @default.
- W4387079244 cites W2119388579 @default.
- W4387079244 cites W2130197019 @default.
- W4387079244 cites W2144733364 @default.
- W4387079244 cites W2152591738 @default.
- W4387079244 cites W2165697122 @default.
- W4387079244 cites W2326928530 @default.
- W4387079244 cites W2418013109 @default.
- W4387079244 cites W2419392911 @default.
- W4387079244 cites W2473619978 @default.
- W4387079244 cites W2482999572 @default.
- W4387079244 cites W2491976234 @default.
- W4387079244 cites W2566961868 @default.
- W4387079244 cites W2736907273 @default.
- W4387079244 cites W2749493591 @default.
- W4387079244 cites W2771307521 @default.
- W4387079244 cites W2785334117 @default.
- W4387079244 cites W2800878103 @default.
- W4387079244 cites W2807164387 @default.
- W4387079244 cites W2811457913 @default.
- W4387079244 cites W2899888975 @default.
- W4387079244 cites W2948151502 @default.
- W4387079244 cites W2956150492 @default.
- W4387079244 cites W2971512351 @default.
- W4387079244 cites W3005496517 @default.
- W4387079244 cites W3007417940 @default.
- W4387079244 cites W3010922574 @default.
- W4387079244 cites W3011964259 @default.
- W4387079244 cites W3014366846 @default.
- W4387079244 cites W3015721656 @default.
- W4387079244 cites W3046227970 @default.
- W4387079244 cites W3088839269 @default.
- W4387079244 cites W3099003222 @default.
- W4387079244 cites W3145890216 @default.
- W4387079244 cites W3164084430 @default.
- W4387079244 cites W3165836291 @default.
- W4387079244 cites W3183110517 @default.
- W4387079244 cites W3184875492 @default.
- W4387079244 cites W4220895732 @default.
- W4387079244 cites W4220917539 @default.
- W4387079244 cites W4225373556 @default.
- W4387079244 cites W4280506043 @default.
- W4387079244 cites W4383822692 @default.
- W4387079244 cites W618357767 @default.
- W4387079244 doi "https://doi.org/10.1021/acs.bioconjchem.3c00347" @default.
- W4387079244 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37758302" @default.
- W4387079244 hasPublicationYear "2023" @default.
- W4387079244 type Work @default.
- W4387079244 citedByCount "0" @default.
- W4387079244 crossrefType "journal-article" @default.
- W4387079244 hasAuthorship W4387079244A5027278009 @default.
- W4387079244 hasAuthorship W4387079244A5047686095 @default.
- W4387079244 hasAuthorship W4387079244A5049327145 @default.
- W4387079244 hasAuthorship W4387079244A5050762779 @default.
- W4387079244 hasAuthorship W4387079244A5056187776 @default.
- W4387079244 hasAuthorship W4387079244A5057401019 @default.
- W4387079244 hasAuthorship W4387079244A5058645388 @default.
- W4387079244 hasAuthorship W4387079244A5082093098 @default.
- W4387079244 hasAuthorship W4387079244A5084244796 @default.
- W4387079244 hasBestOaLocation W43870792441 @default.
- W4387079244 hasConcept C159654299 @default.
- W4387079244 hasConcept C170493617 @default.
- W4387079244 hasConcept C185592680 @default.
- W4387079244 hasConcept C203014093 @default.
- W4387079244 hasConcept C2777863537 @default.
- W4387079244 hasConcept C2778938600 @default.
- W4387079244 hasConcept C2781063702 @default.
- W4387079244 hasConcept C2781072394 @default.
- W4387079244 hasConcept C29144244 @default.
- W4387079244 hasConcept C55493867 @default.
- W4387079244 hasConcept C71924100 @default.
- W4387079244 hasConcept C98274493 @default.
- W4387079244 hasConceptScore W4387079244C159654299 @default.